Get the Stockscreener App
6.11
8.67%
-0.58
Pre-market:
6.03
-0.08
-1.31%
Psyence Biomedical Ltd stock is traded at $6.11, with a volume of 130.39K.
It is down -8.67% in the last 24 hours and up +147.37% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$6.69
Open:
$6.38
24h Volume:
130.39K
Relative Volume:
0.05
Market Cap:
$14.01M
Revenue:
-
Net Income/Loss:
$1.52M
P/E Ratio:
-0.9666
EPS:
-6.3213
Net Cash Flow:
$-1.14M
1W Performance:
-5.86%
1M Performance:
+147.37%
6M Performance:
-63.86%
1Y Performance:
-79.51%
1-Day Range:
$5.85
$6.3827
1-Week Range:
$4.58
$6.9385
52-Week Range:
$0.6254
$74.94
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
6.11 | 14.01M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Psyence Biomedical Ltd Stock (PBM) Latest News
Psyence Biomedical Ltd. Common Shares (PBM) Live Share Price, Invest From India - INDmoney
PBM Forecast, Price Target & Analyst Ratings | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Psyence Biomedical shares rise following equity investment agreement - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Why is Psyence Biomedical stock falling Wednesday? - MSN
Trending Stocks Today | Psyence Biomedical Soars 130.26% Pre-Market - Moomoo
Psyence Biomedical doses first patient in psilocybin cancer trial By Investing.com - Investing.com Australia
PBM jumps on Trump psychedelic push, ibogaine supply story - MSN
Psyence BioMed Begins Phase IIb Dosing of Psilocybin Candidate NPX-5 in Australian Cancer Adjustment Disorder Trial - TipRanks
Psyence BioMed (Nasdaq: PBM) doses first patient in NPX-5 Phase IIb trial - Stock Titan
Why Is Psyence Biomedical Stock Falling Wednesday? - Sahm
Psyence Biomedical doses first patient in psilocybin cancer trial - Investing.com
Psyence Biomedical (PBM) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder - The Manila Times
Psyence Biomedical Ltd. Begins Phase IIb Clinical Trial for NPX-5 Psilocybin Treatment in Cancer Patients - Quiver Quantitative
PBMWW Psyence highlights clinical trial progress as core strategic priority in its latest quarterly earnings release.Community Watchlist - Cổng thông tin điện tử Tỉnh Sơn La
Why is Psyence Biomedical stock trading lower on Tuesday? - MSN
Psyence Biomedical Ltd.Common Shares (NQ:PBM) - FinancialContent
Psyence Biomedical Ltd - Reuters
Psyence Biomedical Tumbles On Heels Of Trump Executive OrderPsyence Biomedical (NASDAQ:PBM) - Benzinga
$Psyence Biomedical (PBM.US)$ hope i timed a good entry on this one - Moomoo
Psyence Biomedical Adds Intraday Equity Purchase Option in White Lion Financing Deal - The Globe and Mail
Is Psyence (PBM) stock a suitable buy candidate (Soars) 2026-04-20Certified Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Top Small Cap Stocks To Keep An Eye OnApril 20th - MarketBeat
What's going on in today's session - ChartMill
Psyence (PBMWW) Stock: Support and Resistance (Technical Strength) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story - Benzinga
These stocks are gapping in today's session - ChartMill
Psyence Biomedical provides update on position in global ibogaine market - TipRanks
$Psyence Biomedical (PBM.US)$ I'm definitely out now. Had to go for one last dip of the Honey pot.🍯 - Moomoo
Top movers in Monday's pre-market session - ChartMill
Morning Market Movers: ENVB, PBM, PASG, ATAI See Big Swings - RTTNews
Psyence Biomedical (PBM) adds intraday stock sale option with White Lion - Stock Titan
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - The Manila Times
Psyence Biomedical Ltd. Advances Strategic Position in Growing Ibogaine Market with Integrated GMP Manufacturing Platform - Quiver Quantitative
Psyence BioMed Positioned as World's Only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - 富途牛牛
$Psyence Biomedical (PBM.US)$ - Moomoo
$Psyence Biomedical (PBM.US)$ missed d opening over my toilet break😅 - Moomoo
Psyence Biomedical (PSYB) Stock: Gains Momentum as GMP Ibogaine Supply Strategy Draws Attention - parameter.io
EO Momo: Why Psychedelics Are in Play - StocksToTrade
Don’t Buy Any of these‼️ Unless you like Cashflow 😏 - Moomoo
Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test - TechStock²
Psyence BioMed Backs Prospective U.S. Ibogaine Review, Citing GMP Supply Leadership - The Globe and Mail
PBM Surges As Psyence Biomedical Rides Ibogaine Policy Wave - timothysykes.com
Trump Trade: President to sign order on psychedelic used for PTSD - Yahoo Finance
Psyence Biomedical Ltd Stock (PBM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):